Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Cherington Charles, Director. Insider active across 4 companies, notably Brooklyn ImmunoTherapeutics, Inc.. Aggregated, 16 filings have been published. Split: 12 buys · 2 sells. Total volume traded: €8.8m. History available since 16 June 2021. The latest transaction was disclosed on 2 April 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
200,000 shares@ US$15.73380.34% mcap50.0% of flowCommon StockSEC:0001140361-21-021772:0
16 of 16 declarations
About Cherington Charles
Charles Cherington is a Director at Brooklyn ImmunoTherapeutics, Inc. He plays a key role in the governance and strategy of the company. Brooklyn ImmunoTherapeutics is a biopharmaceutical company focused on developing immunological treatments. Charles brings valuable expertise in the field, contributing to the company's direction and growth.